Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest update is out from New Ray Medicine International Holding Ltd. ( (HK:6108) ).
New Ray Medicine International Holding Limited has announced a proposal to adopt new Bye-laws to align with the latest regulatory requirements, including the expanded paperless listing regime and mandatory electronic dissemination of corporate communications. These changes aim to modernize the company’s governance structure by allowing electronic and hybrid meetings, providing flexibility to hold treasury shares, and updating provisions according to Bermuda’s laws and the Listing Rules. The adoption of the new Bye-laws is subject to shareholder approval at the upcoming AGM, and no shareholders are required to abstain from voting on this resolution.
More about New Ray Medicine International Holding Ltd.
New Ray Medicine International Holding Limited is a company incorporated in Bermuda with limited liability, and its shares are listed on the Main Board of the Stock Exchange. The company operates within the pharmaceutical industry, focusing on the distribution and development of medical products.
YTD Price Performance: 15.00%
Average Trading Volume: 3,472,238
Technical Sentiment Signal: Hold
Current Market Cap: HK$78.58M
For a thorough assessment of 6108 stock, go to TipRanks’ Stock Analysis page.